Can Urol Assoc J. 2016 May-Jun;10(5):185-186. doi: 10.5489/cuaj.3824.

Addressing the pressing issues related to testosterone administration to men with prostate cancer.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Alvaro Morales

PMID: 27713796 PMCID: PMC5045344 DOI: 10.5489/cuaj.3824

[No abstract available.]

References

1. J Urol. 2002 Jul;168(1):9-12 - PubMed
2. J Urol. 2004 Sep;172(3):920-2 - PubMed
3. J Urol. 2005 Feb;173(2):533-6 - PubMed
4. Cancer. 2007 Feb 1;109(3):536-41 - PubMed
5. BJU Int. 2009 Jan;103(1):62-4 - PubMed
6. Eur Urol. 2009 Feb;55(2):310-20 - PubMed
7. J Urol. 2011 Apr;185(4):1256-60 - PubMed
8. BJU Int. 2011 May;107(9):1369-73 - PubMed
9. Int J Impot Res. 2013 Jan;25(1):24-8 - PubMed
10. J Urol. 2013 Aug;190(2):639-44 - PubMed
11. Public Health Rep. 2015 Mar-Apr;130(2):143-52 - PubMed
12. CMAJ. 2015 Dec 8;187(18):1369-77 - PubMed
13. Maturitas. 2016 Feb;84:94-9 - PubMed
14. Can Urol Assoc J. 2016 May-Jun;10(5-6):181-184 - PubMed
15. Sex Med Rev. 2013 Oct;1(3):143-149 - PubMed
16. Cancer. 1967 Nov;20(11):1871-8 - PubMed
17. Can Med Assoc J. 1970 Aug 15;103(4):372-3 - PubMed
18. Urology. 1999 Feb;53(2):423-4 - PubMed

Publication Types

• Journal Article